The role of sedatives and arousal in obstructive sleep apnoea – pathophysiology and therapeutic utility

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Recent studies indicate that certain sleeping pills (sedatives) may actually reduce obstructive sleep apnoea (OSA) severity in some patients. This research aims to determine the: 1) characteristics of patients who are most likely to respond to this novel approach. 2) effects of commonly prescribed sedatives on upper airway function and breathing during sleep. 3) utility for a sedative to yield sustained reductions in OSA severity and daytime sleepiness in the appropriately selected OSA patients.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Career Development Fellowships

Funding Amount: $415,218.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

arousal | sleep apnoea | sleep breathing disorders | upper airway muscles | upper airway physiology